Bisphosphonate-decorated lipid nanoparticles designed as drug carriers for bone diseases

Journal of Biomedical Materials Research - Part A

Volumn 100 A, Issue 3, 2012, Pages 684-693

  Wang, Guilin ^a   Mostafa, Nesrine Z ^a   Incani, Vanessa ^a   Kucharski, Cezary ^a   Uludaĝ, Hasan ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

bisphosphonate; bone mineral affinity; drug delivery; liposome; micelle

Indexed keywords

ANTICANCER DRUG; BIOACTIVE FACTOR; BISPHOSPHONATES; BONE DISEASE; BONE MINERAL AFFINITY; BONE MORPHOGENETIC PROTEIN-2; BONE TISSUE ENGINEERING; COMPOSITE SCAFFOLDS; DOXORUBICIN; DRUG CARRIER; IN-VITRO; LIPID FILMS; LIPID NANOPARTICLES; LIPOSOMAL FORMULATION; MODEL PROTEINS; NANOCARRIERS; STRONG BINDING; THERAPEUTIC AGENTS;

BONE; DRUG DELIVERY; GLYCOLS; HYDROXYAPATITE; LIPOSOMES; MICELLES; PHOSPHOLIPIDS; POLYETHYLENE GLYCOLS; SILICATE MINERALS; TISSUE;

SCAFFOLDS (BIOLOGY);

2 (3 MERCAPTOPROPYLSULFANYL)ETHYL 1,1 BISPHOSPHONIC ACID; BISPHOSPHONIC ACID DERIVATIVE; BONE MORPHOGENETIC PROTEIN 2; COLLAGEN; DOXORUBICIN; DRUG CARRIER; HYDROXYAPATITE; LIPOSOME; LYSOZYME; MOLECULAR SCAFFOLD; NANOCARRIER; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BONE DISEASE; CONTROLLED STUDY; DRUG BINDING; DRUG DELIVERY SYSTEM; EVAPORATION; FEMALE; IN VITRO STUDY; IN VIVO STUDY; LIPID MEMBRANE; MICELLE; NONHUMAN; OUTCOME ASSESSMENT; RAT; TISSUE ENGINEERING;

ANIMALS; BIOCOMPATIBLE MATERIALS; BONE AND BONES; BONE DENSITY CONSERVATION AGENTS; BONE DISEASES; DIPHOSPHONATES; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; FEMALE; LIPIDS; LIPOSOMES; MATERIALS TESTING; MICELLES; MOLECULAR STRUCTURE; NANOPARTICLES; PARTICLE SIZE; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84856213743     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.34002     Document Type: Article

References (36)

1. Wang D, Miller SC, Kopeckova P, Kopecek J,. Bone-targeting macromolecular therapeutics. Adv Drug Deliv Rev 2005; 57: 1049-1076. (Pubitemid 40692291)
2. Hirabayashi H, Fujisaki J,. Bone-specific drug delivery systems: Approaches via chemical modification of bone-seeking agents. Clin Pharm 2003; 42: 1319-1330. (Pubitemid 38045839)
3. Uludag H,. Bisphosphonates as a foundation of drug delivery to bone. Curr Pharm Des 2002; 8: 1929-1944.
4. Bauss F, Esswein A, Reiff K, Sponer G, Muller-Beckmann B,. Effect of 17β-estradiol-bisphosphonate conjugates, potential bone-seeking estrogen pro-drugs, on 17β-estradiol serum kinetics and bone mass in rats. Calcif Tissue Int 1996; 59: 168-173. (Pubitemid 26275365)
5. Klenner T, Valenzuela-Paz P, Keppler BK, Angres G, Scherf HR, Wingen F, Amelung F, Schmahl D,. Cisplatin-linked phosphonates in the treatment of the transplantable osteosarcoma in vitro and in vivo. Cancer Treat Rev 1990; 17: 253-259.
6. Gil L, Han Y, Opas EE, Rodan GA, Ruel R, Seedor JG, Tyler PC, Young RN,. Prostaglandin E2-bisphosphonate conjugates: Potential agents for treatment of osteoporosis. Bioorg Med Chem 1999; 7: 901-919. (Pubitemid 29238086)
7. Uludag H, Kousinioris N, Gao T, Kantoci D,. Bisphosphonate conjugation to proteins as a means to impart bone affinity. Biotechnol Prog 2000; 16: 258-267. (Pubitemid 30228655)
8. Uludag H, Yang J,. Targeting systemically administered proteins to bone by bisphosphonate conjugation. Biotechnol Prog 2002; 18: 604-611. (Pubitemid 34623235)
9. Gittens SA, Bansal G, Zernicke RF, Uludag H,. Designing proteins for bone targeting. Adv Drug Deliv Rev 2005; 57: 1011-1036. (Pubitemid 40703886)
10. Anada T, Takeda Y, Honda Y, Sakurai K, Suzuki O,. Synthesis of calcium phosphate-binding liposome for drug delivery. Bioorg Med Chem Lett 2009; 19: 4148-4150.
11. Hengst V, Oussoren C, Kissel T, Storm G,. Bone targeting potential of bisphosphonate-targeted liposomes: Preparation, characterization and hydroxyapatite binding in vitro. Int J Pharm 2007; 331: 224-227. (Pubitemid 46216674)
12. Hiramatsu M, Okabe N, Tomita Ki,. Preparation and properties of lysozyme modified by fluorescein-isothiocyanate. J Biochem 1973; 73: 971-978.
13. Bansal G, Wright JEI, Zhang S, Zernicke RF, Uludag H,. Imparting mineral affinity to proteins with thiol-labile disulfide linkages. J Biomed Mater Res A 2005; 74: 618-628. (Pubitemid 41216264)
14. Nickel J, Dreyer MK, Kirsch T, Sebald W,. The Crystal Structure of the BMP-2:BMPR-IA complex and the generation of BMP-2 antagonists. J Bone Joint Surg Am 2001; 83: S7-S14.
15. Bernardi G,. Chromatography of nucleic acids on hydroxyapatite columns. Methods Enzymol 1971; 21: 95-139.
16. Liu XD, Skold M, Umino T, Zhu YK, Romberger DJ, Spurzem JR, Rennard SI,. Endothelial cell-mediated type I collagen gel contraction is regulated by hemin. J Lab Clin Med 2000; 136: 100-109.
17. Cunniffe G, Dickson G, Partap S, Stanton K, O'Brien F,. Development and characterisation of a collagen nano-hydroxyapatite composite scaffold for bone tissue engineering. J Mater Sci Mater Med 2010; 21: 2293-2298.
18. Wang G, Siggers K, Zhang S, Jiang H, Xu Z, Zernicke R, Matyas J, Uludag H,. Preparation of BMP-2 containing bovine serum albumin (BSA) nanoparticles stabilized by polymer coating. Pharm Res 2008; 25: 2896-2909
19. Gao Y, Chen L, Gu W, Xi Y, Lin L, Li Y,. Targeted nanoassembly loaded with docetaxel improves intracellular drug delivery and efficacy in murine breast cancer model. Mol Pharm 2008; 5: 1044-1054.
20. Edwards K, Johnsson M, Karlsson G, Silvander M,. Effect of polyethyleneglycol-phospholipids on aggregate structure in preparations of small unilamellar liposomes. Biophys J 1997; 73: 258-266. (Pubitemid 27274123)
21. Garbuzenko O, Barenholz Y, Priev A,. Effect of grafted PEG on liposome size and on compressibility and packing of lipid bilayer. Chem Phys Lipids 2005; 135: 117-129. (Pubitemid 40744733)
22. Tang N, Du G, Wang N, Liu C, Hang H, Liang W,. Improving penetration in tumors with nanoassemblies of phospholipids and doxorubicin. J Natl Cancer Inst 2007; 99: 1004-1015. (Pubitemid 47232602)
23. Kirby CJ, Gregoriadis G,. Preparation of liposomes containing Factor VIII for oral treatment of haemophilia. J Microencapsul 2008; 1: 33-45.
24. Szoka F, Papahadjopoulos D,. Procedure for preparation of liposomes with large internal aqueous space and high capture by reverse-phase evaporation. Proc Natl Acad Sci USA 1978; 75: 4194-4198. (Pubitemid 9025976)
25. Yamada A, Taniguchi Y, Kawano K, Honda T, Hattori Y, Maitani Y,. Design of folate-linked liposomal doxorubicin to its antitumor effect in mice. Clin Cancer Res 2008; 14: 8161-8168.
26. Jorgensen L, Martins S, van de Weert M,. Analysis of protein physical stability in lipid based delivery systems-The challenges of lipid drug delivery systems. J Biomed Nanotechnol 2009; 5: 401-408.
27. Liu L, Zhang L, Ren B, Wang F, Zhang Q,. Preparation and characterization of collagen-hydroxyapatite composite used for bone tissue engineering scaffold. Artif Cells Blood Substit Biotechnol 2003; 31: 435-448. (Pubitemid 37474289)
28. Immorfino ML, Dosio F, Cattel L,. Stealth liposomes: Review of the basic science, rationale, and clinical applications, existing and potential. Int J Nanomed 2006; 1: 297-315.
29. Matsumura Y, Hamaguchi T, Ura T, Muro K, Yamada Y, Shimada Y, Shirao K, Okusaka T, Ueno H, Ikeda M, Watanabe N,. Phase I clinical trial and pharmacokinetic evaluation of NK911, a micelle-encapsulated doxorubicin. Br J Cancer 2004; 91: 1775-1781. (Pubitemid 39664964)
30. Diaz C, Vargas E, Gatjens-Boniche O,. Cytotoxic effect induced by retinoic acid loaded into galactosyl-sphingosine containing liposomes on human hepatoma cell lines. Int J Pharm 2006; 325: 108-115. (Pubitemid 44573704)
31. Matsuo T, Sugita T, Kubo T, Yasunaga Y, Ochi M, Murakami T,. Injectable magnetic liposomes as a novel carrier of recombinant human BMP-2 for bone formation in a rat bone-defect model. J Biomed Mater Res A 2003; 66: 747-754. (Pubitemid 37521398)
32. Zhang Y, Wang J, Bian D, Zhang X, Zhang Q,. Targeted delivery of RGD-modified liposomes encapsulating both combretastatin A-4 and doxorubicin for tumor therapy: In vitro and in vivo studies. Euro J Pharm Biopharm 2010; 74: 467-473.
33. Neale JR, Richter NB, Merten KE, Taylor KG, Singh S, Waite LC, Emery NK, Smith NB, Cai J, Pierce WM, Jr,. Bone selective effect of an estradiol conjugate with a novel tetracycline-derived bone-targeting agent. Bioorg Med Chem Lett 2009; 19: 680-683.
34. Gilbert M, Giachelli CM, Stayton PS,. Biomimetic peptides that engage specific integrin-dependent signaling pathways and bind to calcium phosphate surfaces. J Biomed Mater Res A 2003; 67: 69-77. (Pubitemid 37517156)
35. Goldberg HA, Warner KJ, Li MC, Hunter GK,. Binding of bone sialoprotein, osteopontin and synthetic polypeptides to hydroxyapatite. Connect Tissue Res 2001; 42: 25-37. (Pubitemid 32894349)
36. Wang G, Kucharski C, Lin X, Uludag H,. Bisphosphonate-coated BSA nanoparticles lacks bone targeting after systemic administration. J. Drug Target 2010; 18: 611-626.